Deutsche Bank expects Amgen to update its 2015 guidance at its business review meeting on February 7. Deutsche thinks the current 2015 earnings outlook of $7.25-$8.60 could be raised to $7.93-$9.25 due to more aggressive share buybacks. The firm notes the current consensus is at the low end of its new projected guidance range. Deutsche keeps a Buy rating on Amgen shares with a $108 price target.
- Investment & Company Information